The role of CTLA-4 in the regulation of T cell immune responses

Immunology and Cell Biology

Volumn 77, Issue 1, 1999, Pages 1-10

  McCoy, Kathy D ^a,b   Le Gros, Graham ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

CD28; Costimulation; CTLA 4; Immune regulation; T lymphocyte

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CELL SURFACE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; HUMANS; IMMUNE TOLERANCE; IMMUNOCONJUGATES; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TH1 CELLS; TH2 CELLS;

EID: 0033029507     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00795.x     Document Type: Review

References (92)

1. 1 Bretscher P, Cohn M. A theory of self-nonself discrimination. Science 1970; 169: 1042-9.
2. 2 Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248: 1349-56.
3. 3 Bretscher P. The two-signal model of lymphocyte activation twenty-one years later. Immunol. Today 1992; 13: 74-6.
4. 4 Lafferty KJ, Gill RG. The maintenance of self-tolerance. Immunol. Cell Biol. 1993; 71: 209-14.
5. 5 Hara T, Fu SM, Hansen JA. Human T cell activation II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen). J. Exp. Med. 1985; 161: 1513-24.
6. 6 Martin PJ, Ledbetter JA, Morishita Y, June CH, Beatty CH, Hansen JA. A 44 kilodalton cell surface homodimer regulates interleukin 2 production by activated human T lymphocytes. J. Immunol. 1986; 136: 3282-7.
7. 7 Damle NK, Doyle LV, Grosmaire LS, Ledbetter JA. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes. J. Immunol. 1988; 140: 1753-61.
8. 8 Lindsten T, June CM, Ledbetter JA, Stella G, Thompson CB. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989; 244: 339-43.
9. 9 Ledbetter JA, Imboden JB, Schieven GL et al. CD28 ligation in T-cell activation: Evidence for two signal transduction pathways. Blood 1990; 75: 1531-9.
10. 10 Van Lier RA, Brouwer M, De Groot ED, Kramer I, Aarden LA, Verhoeven AJ. T cell receptor/CD3 and CD28 use distinct intracellular signaling pathways. Eur. J. Immunol. 1991; 21: 1775-8.
11. 11 June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol. Today 1990; 11: 211-16.
12. 12 Jenkins MK, Taylor PS, Norton SD, Urdahl KB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 1991; 147: 2461-6.
13. 13 Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 1993; 11: 191-212.
14. 14 Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 1991; 173: 721-30.
15. 15 Brunet JF, Denizot F, Luciani MF et al. A new member of the immunoglobulin superfamily: CTLA-4. Nature 1987; 328: 267-70.
16. 16 Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 1991; 147: 1037-44.
17. 17 Howard TA, Rochelle JM, Seldin MF. CD28 and CTLA-4, two related members of the Ig supergene family, are tightly linked on proximal mouse chromosome I. Immunogenetics 1991; 33: 74-6.
18. 18 Lafage-Pochitaloff M, Costello R, Couez D et al. Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics 1990; 31: 198-201.
19. 19 Balzano C, Buonavista N, Rouvier E, Golstein P. CTLA-4 and CD28: Similar proteins, neighbouring genes. Int. J. Cancer 1992; 7: 28-32.
20. 20 Kuiper HM, Brouwer M, Linsley PS, van Lier RA. Activated T cells can induce high levels of CTLA-4 expression on B cells. J. Immunol. 1995; 155: 1776-83.
21. 21 Wagner DH, Hagman J, Linsley PS, Hodsdon W, Freed JH, Newell MK. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 1996; 184: 1631-8.
22. 22 Linsley PS, Greene JL, Tan P et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 1992; 176: 1595-604.
23. 23 Lindsten T, Lee KP, Harris ES et al. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 1993; 151: 3489-99.
24. 24 Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1: 405-13.
25. 25 Dariavach P, Mattei MG, Golstein P, Lefranc MP. Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur. J. Immunol. 1988; 18: 1901-5.
26. 26 Freeman GJ, Lombard DB, Gimmi CD et al. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J. Immunol. 1992; 149: 3795-801.
27. 27 Linsley PS, Bradshaw J, Greene J, Peach R, Bennett KL, Mittler RS. Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 1996; 4: 535-43.
28. 28 Chuang E., Alegre M-L, Duckett CS, Noel PJ, Vander Heiden MG, Thompson CB. Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression. J. Immunol. 1997; 159: 144-51.
29. 29 Shiratori T, Miyatake S, Ohno H et al. Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP-2. Immunity 1997; 6: 583-9.
30. 30 Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 1991; 174: 561-9.
31. 31 Freeman GJ, Borriello F, Hodes RJ et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 1993; 262: 907-9.
32. 32 Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76-9.
33. 33 Peach RJ, Bajorath J, Brady W et al. Complementarity determining region 1 (CDR1)-and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J. Exp. Med. 1994; 180: 2049-58.
34. 34 Damle NK, Klussman K, Leytze G et al. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7. J. Immunol. 1994; 152: 2686-97.
35. 35 Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 1995; 182: 459-65.
36. 36 Linsley PS. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation. J. Exp. Med. 1995; 182: 289-92.
37. 37 Wu Y, Guo Y, Huang A, Zheng P, Liu Y. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 1997; 185: 1327-35.
38. 38 Linsley PS, Greene JL, Brady W, Bajorath J, Ledbetter JA, Peach R. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1994; 1: 793-801.
39. 39 Liu Y. Is CTLA-4 a negative regulator for T-cell activation? Immunol. Today 1997; 18: 569-72.
40. 40 Gribben JG, Freeman GJ, Boussiotis VA et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc. Natl Acad. Sci. USA 1995; 92: 811-15.
41. 41 Walunas TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 1996; 183: 2541-50.
42. 42 Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 1996; 183: 2533-40.
43. 43 Allison JP, Krummel MF. The yin and yang of T cell costimulation. Science 1995; 270: 932-3.
44. 44 Kearney ER, Walunas TL, Karr RW et al. Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. J. Immunol. 1995; 155: 1032-6.
45. 45 Krummel MF, Sullivan TJ, Allison JP. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. Int. Immunol. 1996; 8: 519-23.
46. 46 Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996; 271: 1734-6.
47. 47 McCoy KD, Camberis M, Le Gros G. Protective immunity to nematode infection is induced by CTLA-4 blockade. J. Exp. Med. 1997; 186: 183-7.
48. 48 Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML. Cytotoxic T lymphocyte antigen 4 (CTLA-4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA-4 can function independently of CD28. J. Exp. Med. 1998; 188: 199-204.
49. 49 Fallarino F, Fields PE, Gajewski TF. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. J. Exp. Med. 1998; 188: 205-10.
50. 50 Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995; 3: 541-7.
51. 51 Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 1995; 270: 985-8.
52. 52 Tivol EA, Boyd SD, McKeon S et al. CTLA-4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J. Immunol. 1997; 158: 5091-4.
53. 53 Chambers CA, Sullivan TJ, Allison JP. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 1997; 7: 885-95.
54. 54 Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-56.
55. 55 Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-62.
56. 56 Linsley PS, Golstein P. Lymphocyte activation: T-cell regulation by CTLA-4. Curr. Biol. 1996; 6: 398-400.
57. 57 Waterhouse P, Bachmann MF, Penninger JM, Ohashi PS, Mak TW. Normal thymic selection, normal viability and decreased lymphoproliferation in T cell receptor-transgenic CTLA-4-deficient mice. Eur. J. Immunol. 1997; 27: 1887-92.
58. 58 Chambers CA, Cado D, Truong T, Allison JP. Thymocytc development is normal in CTLA-4-deficient mice. Proc. Natl Acad. Sci. USA 1997; 94: 9296-301.
59. 59 Waterhouse P, Marengere LE, Mittrucker HW, Mak TW. CTLA-4, a negative regulator of T-lymphocyte activation. Immunol. Rev. 1996; 153: 183-207.
60. 60 Miyatake S, Nakaseko C, Umemori H, Yamamoto T, Saito T. Src family tyrosine kinases associate with and phosphorylate CTLA-4 (CD152). Biochem. Biophys. Res. Commun. 1998; 249: 444-8.
61. 61 Stein PH, Fraser JD, Weiss A. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol. Cell. Biol. 1994; 14: 3392-402.
62. 62 Schneider H, Prasad KV, Shoelson SE, Rudd CE. CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 1995; 181: 351-5.
63. 63 Calvo CR, Amsen D, Kruisbeek AM. Cytotoxic T lymphocyte antigen 4 (CTLA-4) interferes with extracellular signal-regulated kinase (ERK) and Jun NH2-terminal kinase (JNK) activation, but does not affect phosphorylation of T cell receptor zeta and ZAP70. J. Exp. Med. 1997; 186: 1645-53.
64. 64 Fraser H, Rincon M, McCoy KD, Le Gros G. CTLA-4 inhibits AP-1 NFAT and NFκB transcriptional activity. Eur. J. Immunol. (in press).
65. 65 Marengere LE, Waterhouse P, Duncan GS, Mittrucker HW, Feng GS, Mak TW. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 1996; 272: 1170-3.
66. 66 Leung HT, Bradshaw J, Cleaveland JS, Linsley PS. Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. J. Biol. Chem. 1995; 270: 25 107-14.
67. 67 Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 1995; 80: 707-18.
68. 68 Miller SD, Vanderlugt CL, Lenschow DJ et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity 1995; 3: 739-45.
69. 69 Lenschow DJ, Bluestone JA. T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 1993; 5: 747-52.
70. 70 Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: A negative regulator of autoimmune disease. J. Exp. Med. 1996; 184: 783-8.
71. 71 Perrin PJ, Maldonado JH, Davis TA, June CH, Racke MK. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol. 1996; 157: 1333-6.
72. 72 Lühder F, Höglund P, Allison JP, Benoist C, Mathis D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 1998; 187: 427-32.
73. 73 MacKay CR. Homing of naive, memory and effector lymphocytes. Curr: Opin. Immunol. 1993; 5: 423-7.
74. 74 Nistico L, Buzzetti R, Pritchard LE et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum. Mol. Genet. 1996; 5: 1075-80.
75. 75 Todd JA, Farrall M. Panning for gold: Genome-wide scanning for linkage in type 1 diabetes. Hum. Mol. Genet. 1996; 5: 1443-8.
76. 76 Awata T, Kurihara S, Iitaka M et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes 1998; 47: 128-9.
77. 77 Marron MP, Raffel LJ, Garchon HJ et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum. Mol. Genet. 1997; 6: 1275-82.
78. 78 Krokowski M, Bodalski J, Bratek A, Machejko P, Caillat-Zucman S. CTLA-4 gene polymorphism is associated with predisposition to IDDM in a population from central Poland. Diabete Metab. 1998; 24: 241-3.
79. 79 Van der Auwera BJ, Vandewalle CL, Schuit FC et al. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin. Exp. Immunol. 1997; 110: 98-103.
80. 80 Donner H, Rau H, Walfish PG et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type I diabetes mellitus. J. Clin. Endocrinol. Metab. 1997; 82: 143-6.
81. 81 Yanagawa T, Taniyama M, Enomoto S et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997; 7: 843-6.
82. 82 Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin. Endocrinol. 1997; 46: 551-4.
83. 83 Perez VL, Van Parijs L, Biuckians A, Zheng XX, Strom TB, Abbas AK. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 1997; 6: 411-17.
84. 84 Fazekas de Groth B. The evolution of self tolerance (Abstract). In: Australasian Society for Immunology, 27th Annual Meeting Abstract Book Perth: University of Western Australia, 1997; 46.
85. 85 Shaw AS, Dustin ML. Making the T cell receptor go the distance: A topological view of T cell activation. Immunity 1997; 6: 361-9.
86. 86 Janeway Jr CA, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76: 275-85.
87. 87 Mondino A, Khoruts A, Jenkins MK. The anatomy of T-cell activation and tolerance. Proc. Natl Acad. Sci. USA 1996; 93: 2245-52.
88. 88 Chambers CA, Krummel MF, Boitel B et al. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 1996; 153: 27-46.
89. 89 Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J. Immunol. 1997; 158: 1989-93.
90. 90 Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997; 7: 445-50.
91. 91 Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 1997; 276: 2057-62.
92. 92 Green JM, Noel PJ, Sperling Al et al. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1994; 1: 501-8.